Becton Dickinson Stock Forecast
NYSE: BDXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
BDX analyst consensus
Consensus (15 analysts)
buy
Avg. price target
$194.08+6.20%
- Strong buy 1
- Buy 6
- Hold 7
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 15 Wall Street analysts covering Becton Dickinson (2026-10-07), 7 rate the stock a buy or strong buy, 7 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $194.08, with a high estimate of $225.00 and a low estimate of $165.00. The average target implies upside of 6.2% from the current price of $182.75.
The spread between the highest and lowest targets is 36.4%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for BDX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 7% |
| Buy | 6 | 40% |
| Hold | 7 | 47% |
| Sell | 0 | 0% |
| Strong sell | 1 | 7% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $165.00 | -9.71% |
| Average target | $194.08 | +6.20% |
| High target | $225.00 | +23.12% |